Compound information
- Natural Products
- ZC1580442
- Molecular Formula
- C20H22NO8P
- Molecular Weight
- 435.108303294 g/mol
- Structure
-
- IUPAC Name
- 2-[[[(1S)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]-hydroxy-phosphoryl]methyl]propanedioic acid
- InChI
- InChI=1S/C20H22NO8P/c22-18(23)16(19(24)25)13-30(27,28)17(11-14-7-3-1-4-8-14)21-20(26)29-12-15-9-5-2-6-10-15/h1-10,16-17H,11-13H2,(H,21,26)(H,22,23)(H,24,25)(H,27,28)/t17-/m0/s1
- InChI Key
- HMYUTAVMRPOHIX-KRWDZBQOSA-N
- SMILES
- O=C(N[C@H](Cc1ccccc1)[P@](=O)(O)CC(C(=O)O)C(=O)O)OCc1ccccc1
- Source
- ZINC000137558218
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 150.23 Å2 | LogP | 1.382 |
LogS | -2.844 | LogD | -0.088 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.419 |
HIA | 0.815 | F20 % | 0.46 |
F30 % | 0.008 | Caco-2 | -6.666 |
MDCK | -5.89 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.067 | PPB | 95.697 |
VD | 0.37 | Fu | 1.36 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.429 |
CYP2A6 substrate | 0.227 | CYP2B6 substrate | 0.397 |
CYP2C19 inhibitor | 0.071 | CYP2C19 substrate | 0.591 |
CYP2C8 substrate | 0.521 | CYP2C9 inhibitor | 0.008 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.133 |
CYP2D6 substrate | 0.197 | CYP2E1 substrate | 0.192 |
CYP3A4 inhibitor | 0.007 | CYP3A4 substrate | 0.272 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.896 | CL | 0.72 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.665 | Hepatotoxicity | 0.924 |
Mutagenicity | 0.17 | Rat Oral Acute Toxicity | 0.052 |
FDAMDD | 0.153 | Skin Sensitization | 0.225 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.006 |
Eye Irritation | 0.441 | Respiratory Toxicity | 0.164 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.083 | IGC50 | 2.288 |
LC50FM | 3.533 | LC50DM | 4.826 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.597 | NR-AR-LBD | 0.51 |
NR-AhR | 0.004 | NR-Aromatase | 0.026 |
NR-ER | 0.434 | NR-ER-LBD | 0.244 |
NR-PPAR-gamma | 0.122 | SR-ARE | 0.002 |
SR-ATAD5 | 0.219 | SR-HSE | 0.001 |
SR-MMP | 0.0 | SR-p53 | 0.073 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.